Search
Home
News
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Coins2Day 500
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Pfizer
Pfizer
Pfizer (PFE) Q3 2025 Earnings Call Transcript
By
Tech Reporter
November 4, 2025
Law
Pfizer strikes $70B deal with Trump to cut Medicaid drug prices, expand American manufacturing under tariff threat
By
Tom Murphy
,
Michelle S. Price
and
The Associated Press
September 30, 2025
Success
CEO says his son is among Gen Zers questioning whether a college degree is worth it: ‘Is this education a scam?’
By
Blockchain Reporter
September 17, 2025
Pfizer (PFE) Q2 2025 Earnings Call Transcript
By
Research Team
August 5, 2025
Leadership
Summer Fridays are dead because remote work killed them
By
Trading Desk
July 3, 2025
Workplace Culture
Ireland sees thousands of jobs at risk from U.S. pharma tariffs
By
Olivia Fletcher
,
Stephen Carroll
and
Bloomberg
June 23, 2025
Politics
Court rejects European Commission’s refusal to share texts between von der Leyen and Pfizer CEO during COVID pandemic
By
Sam McNeil
and
The Associated Press
May 15, 2025
Pfizer (PFE) Q1 2025 Earnings Call Transcript
By
Senior Editor
April 29, 2025
Newsletters
Pfizer CEO Albert Bourla sees ‘a scientific renaissance’ in the U.S. amid backdrop of political threats to the future of research
By
Investment Desk
April 24, 2025
Commentary
The faulty forecasts of pharma firm investors: Misguided cynics miss the promising prognosis for drugmakers Pfizer and Merck
By
Jeffrey Sonnenfeld
and
Steven Tian
February 5, 2025
Health
Pfizer CEO had dinner with RFK Jr.: ‘I’m cautiously optimistic’ in spite of his history with vaccines
By
Tech Reporter
February 4, 2025
Health
Pfizer’s Covid boost overshadowed by Kennedy threat to vaccines
By
Bloomberg
and
Damian Garde
February 4, 2025
Pfizer (PFE) Q4 2024 Earnings Call Transcript
By
Trading Desk
February 4, 2025
Health
As bird flu becomes a growing threat, Moderna is awarded $590M to develop mRNA pandemic influenza vaccines
By
Editorial Team
January 23, 2025
Health
Hate needles? Lilly’s weight-loss pill could get FDA approval next year, CEO says
By
Investment Desk
January 22, 2025
Most Popular
AI
Elon Musk says that in 10 to 20 years, work will be optional and money will be irrelevant thanks to AI and robotics
By
Tech Reporter
Big Tech
Nvidia CEO says the company is in a no-win situation amid AI-bubble chatter, leaked meeting reveals
By
Industry Analyst
Economy
One of the world’s most popular economists on why AI is ‘undoubtedly going to crash’: It’s built off ‘digital...
By
Staff Writer